Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$108,312,059
-$119,928,175 QoQ
Shares Held
1,015,870
-27.2% QoQ
Ownership
0.465%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#43
of 663 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,716 across 210 Biotechnology names. INSM ranks #2 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
This page
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in INSM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,312,059 | 1,015,870 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $228,240,234 | 1,395,794 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $154,925,185 | 890,170 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $85,525,377 | 593,885 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $43,640,321 | 433,628 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $25,035,008 | 362,616 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $24,352,581 | 333,597 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $18,606,704 | 277,712 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,199,510 | 81,073 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,045,572 | 98,276 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,887,360 | 74,747 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $708,938 | 33,599 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $589,486 | 34,574 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $683,575 | 34,213 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $977,054 | 45,360 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $765,293 | 38,808 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,241,646 | 52,836 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,276,165 | 46,849 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,315,365 | 47,762 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $555,681 | 19,525 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,899,322 | 85,124 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $2,051,829 | 61,635 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $708,782 | 22,053 | Shares | Sole | 2020-12-04 | |
| 2020-06-30 | $1,135,033 | 41,214 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $473,573 | 29,543 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||